INOVIO PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-88.2M | $-73.7M | $-29.2M | $-36.1M | $-66.0M | $-19.7M | $-15.3M | $-17.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $1.9M | $1.7M | $1.0M | $626.6K | $328.8K | $173.8K | $142.2K | $194.6K |
| Amortization | $1.6M | $1.4M | $870.2K | $942.7K | $1.8M | $1.8M | $1.9M | $1.9M |
| Stock-Based Compensation | $13.1M | $10.5M | $6.2M | $5.4M | $1.9M | $1.3M | $1.7M | $1.2M |
| Net Cash from Operating Activities | $-63.2M | $-62.6M | $-12.4M | $-29.8M | $-15.4M | $-22.3M | $-19.8M | $-11.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $10.3M | $2.7M | $2.8M | $1.4M | $176.9K | $241.0K | $161.2K | $181.6K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-27.8M | $16.3M | $-54.8M | $-35.8M | $-9.2M | $5.3M | $-10.9M | $11.4M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $95.7M | $7.8M | $84.4M | $72.5M | $52.7M | $5.3M | $28.0M | $-9.7M |
| Net Change in Cash | $4.7M | $-38.5M | $17.1M | $6.8M | $28.1M | $-11.7M | $-2.6M | $-10.3M |
| Free Cash Flow | $-73.5M | $-65.3M | $-15.2M | $-31.2M | $-15.6M | $-22.5M | $-19.9M | $-12.1M |